Category: Point-of-Care
Point-of-Care market research reports by Frost & Sullivan
-
Frost Radar™: Clinical Decision Support Systems in North America, 2025
This Frost Radar™ benchmarks the growth and innovation activity of clinical decision support system (CDSS) vendors in their effort to provide end users with evidence to take the next best action. The CDSS role is evolving from just being the source of clinical knowledge at the point of care or facil ... Read More
-
Global Clinical Diagnostics Outlook, 2024
Global Clinical Diagnostics Outlook, 2024 Driven by Digital Services and Automation, the Molecular Diagnostics and POCT Sectors Rebound after the COVID-19 Pandemic With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare ... Read More
-
Direct-to-Consumer Wellness Testing Growth Opportunities
Direct-to-Consumer Wellness Testing Growth Opportunities The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling optio ... Read More
-
Global Point-of-care Testing Growth Opportunities
Global Point-of-care Testing Growth Opportunities This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID- ... Read More
-
Frost Radar™: Point-of-Care Ultrasound (Portable and Ultraportable), 2023
Frost Radar™: Point-of-Care Ultrasound (Portable and Ultraportable), 2023 A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines Portable and ultraportable point-of-care ultrasound (POCUS) systems have gained prominence in recent years due to th ... Read More
-
Asia-Pacific Next-generation Diagnostics Outlook, 2023
Asia-Pacific Next-generation Diagnostics Outlook, 2023 The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attri ... Read More
-
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025 Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with c ... Read More
-
United States Molecular Point-of-Care Testing Growth Opportunities
United States Molecular Point-of-Care Testing Growth Opportunities Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testi ... Read More
-
Next-generation Diagnostics Outlook, 2022
Next-generation Diagnostics Outlook, 2022 In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosi ... Read More
Research Assistance
